ACB - Aurora Cannabis Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Edmonton,
Canada
Type: Equity
ACB price evolution
ACB
| (in millions $) | 1 May 2025 | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $40.15 | $30.63 | $45.41 | |
| Inventory | $212.2 | $201.96 | $186.38 | |
| Total current assets | $417.68 | $439.37 | $426.61 | |
| Long term investments | ||||
| Property, plant & equipment | $276.48 | $283.73 | $294.32 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $808.77 | $838.69 | $838.67 | |
| Current liabilities | ||||
| Accounts payable | $8.73 | $10.62 | $20.32 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $109.09 | $116.8 | $124.62 | |
| Long term debt | $42.22 | $48.08 | $47.57 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $265.6 | $277.07 | $278.9 | |
| Shareholders' equity | ||||
| Retained earnings | -$6136.77 | -$6120.82 | -$6122.77 | |
| Other shareholder equity | -$297.1 | -$291.11 | -$288.87 | |
| Total shareholder equity | ||||
| (in millions $) | 1 May 2024 | 30 Jul 2022 | 30 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $344.13 | $120.92 | ||
| Short term investments | ||||
| Net receivables | $45.41 | $47.05 | $44.09 | $40.34 |
| Inventory | $186.38 | $139.93 | $107.5 | $117.25 |
| Total current assets | $426.61 | $745.12 | $519.8 | $313.7 |
| Long term investments | ||||
| Property, plant & equipment | $294.32 | $233.47 | $473.12 | $705.62 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1513.46 | $1761.82 | ||
| Total investments | ||||
| Total assets | $838.67 | $1084.36 | $2033.25 | $2075.52 |
| Current liabilities | ||||
| Accounts payable | $20.32 | $13.86 | $45.52 | $85.88 |
| Deferred revenue | $3.25 | $2.63 | ||
| Short long term debt | ||||
| Total current liabilities | $124.62 | $145.23 | $90.84 | $203.4 |
| Long term debt | $47.57 | $236.49 | $358.61 | $62.41 |
| Total noncurrent liabilities | $351.78 | $286.64 | ||
| Total debt | ||||
| Total liabilities | $278.9 | $422.51 | $442.62 | $490.04 |
| Shareholders' equity | ||||
| Retained earnings | -$6122.77 | -$5794.68 | -$3373.04 | -$2678.78 |
| Other shareholder equity | -$288.87 | -$298.1 | -$51.14 | -$49.33 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81.12 | $83.44 | $67.41 | $64.42 |
| Cost of revenue | ||||
| Gross Profit | $3.17 | -$2.92 | $2.65 | -$2.94 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $43.57 | $42.67 | $45.05 | $42.13 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$1.07 | $2.86 | -$0.71 | -$0.07 |
| Interest expense | $2.95 | $3.45 | $6.43 | $0.52 |
| Net income | ||||
| Net income | -$12.04 | $6.52 | -$13.66 | -$24.5 |
| Income (for common shares) | ||||
| (in millions $) | 1 May 2024 | 30 Jul 2022 | 30 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $270.28 | $221.34 | $191.44 | $207.95 |
| Cost of revenue | ||||
| Gross Profit | -$3.13 | -$97.45 | -$16.83 | -$25.01 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $172.59 | $247.98 | $204.21 | $342.01 |
| Operating income | -$220.77 | -$366.06 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.55 | -$2.14 | -$4.93 | -$62.19 |
| Interest expense | $9.89 | -$6.68 | $51.86 | $57.81 |
| Net income | ||||
| Net income | -$65.58 | -$1717.62 | -$542.59 | -$2468.19 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$2.82 | $0.81 | -$5.49 | $0.75 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$3.24 | -$6.31 | -$47.92 | -$43.05 |
| Effect of exchange rate | -$5.94 | $0.06 | $0.3 | -$0.89 |
| Change in cash and equivalents | -$28.52 | $2.05 | -$121.5 | -$90.57 |
| (in millions $) | 1 May 2024 | 30 Jul 2022 | 30 Jul 2021 | 29 Jul 2020 |
|---|---|---|---|---|
| Net income | -$541.33 | -$2460.85 | ||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$164.38 | -$251.98 | ||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$5.49 | -$36.6 | -$21 | -$186.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$47.92 | $147.78 | $407.44 | $434.36 |
| Effect of exchange rate | $0.3 | $15.01 | -$19.67 | -$4.23 |
| Change in cash and equivalents | -$121.5 | $16.35 | $202.39 | -$7.86 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $296.39M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$43.68M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |